{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:06:55Z","timestamp":1790446015135,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.taap.2021.115513","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T12:06:33Z","timestamp":1616846793000},"page":"115513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca2+ channels as sensors"],"prefix":"10.1016","volume":"419","author":[{"given":"Iwona","family":"Ruchala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto M.","family":"Battisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Yu-Tzu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Glennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Eltit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115513_bb0005","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/acschemneuro.9b00262","article-title":"Identification of a novel allosteric modulator of the human dopamine transporter","volume":"10","author":"Aggarwal","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2021.115513_bb0010","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1021\/acschemneuro.6b00164","article-title":"Interrogating the molecular basis for substrate recognition in serotonin and dopamine transporters with high-affinity substrate-based bivalent ligands","volume":"7","author":"Andersen","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2021.115513_bb0015","doi-asserted-by":"crossref","first-page":"100004","DOI":"10.1016\/j.etdah.2021.100004","article-title":"A strategy to prioritize emerging drugs of abuse for analysis: abuse liability testing using intracranial self-stimulation (ICSS) in rats and validation with \u03b1-pyrrolidinohexanophenone (\u03b1-PHP)","volume":"1","author":"Baird","year":"2021","journal-title":"Emerg. Drugs Addict. Health"},{"key":"10.1016\/j.taap.2021.115513_bb0020","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1021\/acschemneuro.8b00138","article-title":"Effects of N-alkyl-4-methylamphetamine optical isomers on plasma membrane monoamine transporters and abuse-related behavior","volume":"9","author":"Battisti","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2021.115513_bb0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/0269881113487950","article-title":"4-Methyl-amphetamine: a health threat for recreational amphetamine users","volume":"27","author":"Blanckaert","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.taap.2021.115513_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00213-013-3223-5","article-title":"Abuse-related and abuse-limiting effects of methcathinone and the synthetic \u201cbath salts\u201d cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats","volume":"231","author":"Bonano","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.taap.2021.115513_bb0035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/311570a0","article-title":"The agonist effect of dihydropyridines on Ca channels","volume":"311","author":"Brown","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115513_bb0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ceca.2015.06.013","article-title":"Amphetamine activates calcium channels through dopamine transporter-mediated depolarization","volume":"58","author":"Cameron","year":"2015","journal-title":"Cell Calcium"},{"key":"10.1016\/j.taap.2021.115513_bb0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature12354","article-title":"Ultrasensitive fluorescent proteins for imaging neuronal activity","volume":"499","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115513_bb0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/00397918708075741","article-title":"Transformation of aromatic nitroalkanes into carbonyl-compounds by the improved Nef reaction","volume":"17","author":"Chikashita","year":"1987","journal-title":"Synthet. Commun."},{"key":"10.1016\/j.taap.2021.115513_bb0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-019-1135-1","article-title":"Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport","volume":"569","author":"Coleman","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115513_bb0060","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1007\/s00213-019-05339-4","article-title":"Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and alpha-pyrrolidinopentiophenone (alpha-PVP) in rhesus monkeys","volume":"236","author":"Collins","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.taap.2021.115513_bb0065","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1038\/s41467-019-12264-9","article-title":"Plasticity in striatal dopamine release is governed by release-independent depression and the dopamine transporter","volume":"10","author":"Condon","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.taap.2021.115513_bb0070","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/acschemneuro.9b00617","article-title":"Investigation of the optical isomers of methcathinone, and two achiral analogs, at monoamine transporters and in intracranial self-stimulation studies in rats","volume":"11","author":"Davies","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2021.115513_bb0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2017.02.003","article-title":"Monoamine transporters as ionotropic receptors","volume":"40","author":"De Felice","year":"2017","journal-title":"Trends Neurosci."},{"issue":"Suppl. 4","key":"10.1016\/j.taap.2021.115513_bb0080","first-page":"4","article-title":"Mechanism of action of antidepressant medications","volume":"60","author":"Feighner","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.taap.2021.115513_bb0085","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.1073\/pnas.95.16.9238","article-title":"Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter","volume":"95","author":"Ferrer","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2021.115513_bb0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.pharmtox.47.120505.105140","article-title":"New insights into the mechanism of action of amphetamines","volume":"47","author":"Fleckenstein","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2021.115513_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(85)90631-4","article-title":"The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels","volume":"114","author":"Franckowiak","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115513_bb0100","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1242\/jeb.198.10.2197","article-title":"Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants","volume":"198","author":"Galli","year":"1995","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.taap.2021.115513_bb0105","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41386-018-0209-3","article-title":"The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter","volume":"43","author":"Gannon","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.taap.2021.115513_bb0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-420118-7.00004-4","article-title":"Monoamine transporter inhibitors and substrates as treatments for stimulant abuse","volume":"69","author":"Howell","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.taap.2021.115513_bb0115","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1016\/j.bmcl.2014.07.038","article-title":"Design, synthesis and in vitro evaluation of novel uni- and bivalent ligands for the cannabinoid receptor type 1 with variation of spacer length and structure","volume":"24","author":"Huang","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.taap.2021.115513_bb0120","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nn920","article-title":"Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons","volume":"5","author":"Ingram","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.taap.2021.115513_bb0125","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0378-4347(94)00479-O","article-title":"Gas chromatographic determination of methamphetamine and its metabolite amphetamine in human plasma and urine following conversion to N-propyl derivatives","volume":"664","author":"Jacob","year":"1995","journal-title":"J. Chromatogr. B Biomed. Appl."},{"key":"10.1016\/j.taap.2021.115513_bb0130","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1021\/cn400038u","article-title":"APP+, a fluorescent analogue of the neurotoxin MPP+, is a marker of catecholamine neurons in brain tissue, but not a fluorescent false neurotransmitter","volume":"4","author":"Karpowicz","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2021.115513_bb0135","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2021.115513_bb0140","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0896-6273(94)90337-9","article-title":"Conducting states of a mammalian serotonin transporter","volume":"12","author":"Mager","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.taap.2021.115513_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/17425255.2019.1584611","article-title":"Pharmacokinetics of serotonergic drugs: focus on OCD","volume":"15","author":"Marazziti","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2021.115513_bb0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1124\/jpet.118.250902","article-title":"Interactions between cocaine and the putative allosteric dopamine transporter ligand SRI-31142","volume":"367","author":"Moerke","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115513_bb0155","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00004872-199006002-00003","article-title":"Antihypertensive medications: relative effectiveness and adverse reactions","volume":"8","author":"Moser","year":"1990","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.taap.2021.115513_bb0160","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1124\/pr.112.007419","article-title":"Intracranial self-stimulation to evaluate abuse potential of drugs","volume":"66","author":"Negus","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2021.115513_bb0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1196\/annals.1369.064","article-title":"Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs","volume":"1074","author":"Rothman","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.taap.2021.115513_bb0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ceca.2014.04.003","article-title":"Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels","volume":"56","author":"Ruchala","year":"2014","journal-title":"Cell Calcium"},{"key":"10.1016\/j.taap.2021.115513_bb0175","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1471-4159.2010.06583.x","article-title":"Bivalent phenethylamines as novel dopamine transporter inhibitors: evidence for multiple substrate-binding sites in a single transporter","volume":"112","author":"Schmitt","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2021.115513_bb0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/303535a0","article-title":"Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels","volume":"303","author":"Schramm","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115513_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1060028013510699","article-title":"A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD)","volume":"48","author":"Sharma","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.taap.2021.115513_bb0190","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1074\/jbc.M111.267757","article-title":"4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP+) is a fluorescent substrate for the human serotonin transporter","volume":"287","author":"Solis","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2021.115513_bb0195","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/npp.2017.98","article-title":"N-alkylated analogs of 4-methylamphetamine (4-MA) differentially affect monoamine transporters and abuse liability","volume":"42","author":"Solis","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.taap.2021.115513_bb0200","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1523\/JNEUROSCI.17-03-00960.1997","article-title":"Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants","volume":"17","author":"Sonders","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2021.115513_bb0205","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00213-018-5103-5","article-title":"Using Ca(2+)-channel biosensors to profile amphetamines and cathinones at monoamine transporters: electro-engineering cells to detect potential new psychoactive substances","volume":"236","author":"Steele","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.taap.2021.115513_bb0210","series-title":"World Drug Report 2019","first-page":"4","author":"UNODC","year":"2019"},{"key":"10.1016\/j.taap.2021.115513_bb0215","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/386827a0","article-title":"Relationship between subjective effects of cocaine and dopamine transporter occupancy","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115513_bb0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/026988119901300406","article-title":"Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans","volume":"13","author":"Volkow","year":"1999","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.taap.2021.115513_bb0225","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature14431","article-title":"Neurotransmitter and psychostimulant recognition by the dopamine transporter","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115513_bb0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","article-title":"Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"19","author":"Watterson","year":"2014","journal-title":"Addict. Biol."},{"key":"10.1016\/j.taap.2021.115513_bb0235","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1124\/jpet.104.080101","article-title":"Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs","volume":"313","author":"Wee","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115513_bb0240","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1021\/acschemneuro.9b00284","article-title":"Synthetic cathinone analogues structurally related to the central stimulant methylphenidate as dopamine reuptake inhibitors","volume":"10","author":"Yadav-Samudrala","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.taap.2021.115513_bb0245","first-page":"734","article-title":"Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations","volume":"40","author":"Zheng","year":"1991","journal-title":"Mol. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21001204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21001204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:53:57Z","timestamp":1758574437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21001204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":49,"alternative-id":["S0041008X21001204"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115513","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca2+ channels as sensors","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115513"}}